Across TCGA pan-cancer cohorts, EEF1B2P5 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of EEF1B2P5’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where EEF1B2P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EEF1B2P5 is over-expressed in tumor.
COAD are the cancer types where EEF1B2P5 tumor–normal differential expression is most reproducible.